COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents

Mini-Reviews in Medicinal Chemistry

Volumn 4, Issue 6, 2004, Pages 625-632

  Supuran, Claudiu T ^a   Casini, Angela ^a   Mastrolorenzo, Antonio ^a   Scozzafava, Andrea ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ACETAZOLAMIDE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BRINZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CELECOXIB; CEREBREX; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; HISTIDINE; INDOMETACIN DERIVATIVE; ISOENZYME; METHAZOLAMIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE; PLATINUM DERIVATIVE; ROFECOXIB; SULFONAMIDE; UNINDEXED DRUG; VALDECOXIB; ZINC ION; ZOMEPIRAC;

ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CARCINOGENESIS; DIURETIC ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GROWTH INHIBITION; HUMAN; NONHUMAN; SHORT SURVEY; SIDE EFFECT; STRUCTURE ANALYSIS; TUMOR GROWTH;

EID: 3242668792     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557043403792     Document Type: Short Survey

References (50)

1. Vane, J.R. J. Physiol. Pharmacol. 2000, 51, 573-586.
2. Marnett, L.J. Curr. Opin. Chem. Biol. 2000, 4, 545-552.
3. Chandrasekharan, N.V., Dai, H., Roos, K.L.T., Evanson, N.K.; Tomsik, J., Elton, T.S., Simmons, D.L. Proc. Natl. Acad. Sci. USA 2002, 99, 13926-13932.
4. Talley, J.J. Exp. Opin. Ther. Patents 1997, 7, 55-62.
5. FitzGerald, G. A:, Patrono, C. N. Engl. J. Med. 2001, 345, 433-442.
6. Flower, R. J. Nat. Rev. Drug Discov. 2003, 2, 179-191.
7. Subbaramaiah, K., Dannenberg, A.J. Trends Pharmacol. Sci. 2003, 24, 96-102.
8. Zweifel, B.S., Davis, T.W., Ornberg, R.L., Masferrer, J.L. Cancer Res. 2002, 62, 6706-6711.
9. Kundu, N., Smyth, M.J., Samsel, L., Fulton, A.M. Breast Cancer Res. Treat. 2002, 76, 57-64.
10. Wang, Z., Fuentes, C. F., Shapshay, S.M. Laryngoscope 2002, 112, 839-843.
11. Stratton, M.S., Alberts, D.S. Oncology (Huntingt,) 2002, 16 suppl. 4, 37-51.
12. Orengo, I.F., Gerguis, J., Phillips, R., Guevara, A., Lewis, A.T., Black, H.S. Arch. Dermatol. 2002, 138, 751-755.
13. Phillips, R.K., Wallace, M.H., Lynch, P.M., Hawk, E., Gordon, G.B., Saunders, B.P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., Rodrigues-Bigas, M., Su, L.K., Sherman, J., Kelloff, G., Levin, B., Steinbach, G.; FAP Study Group. Gut 2002, 50, 857-860.
14. Waskewich, C., Blumenthal, R.D., Li, H., Stein, R., Goldenberg, D.M., Burton, J. Cancer Res. 2002, 62, 2029-2033.
15. Williams, C.S., Shattuck-Brandt, R.L., DuBois, R.N. Exp. Opin. Invest. Drugs 1999, 8, 1-12.
16. Menter, D.G. Exp. Opin. Invest. Drugs 2002, 11, 1749-1764.
17. Crosby, C.G., DuBois, R.N. Exp. Opin. Emerg. Drugs 2003, 8, 1-7.
18. Jacoby, R.F., Seibert, K., Cole, C.E., Kelloff, G., Lubet, R.A. Cancer Res. 2000, 60, 5040-5044.
19. Nakanishi, Y., Kamijo, R., Takizawa, K., Hatori, M., Nagumo, M. Eur. J. Cancer 2001, 37, 1570-1578.
20. Weber, A., Casini, A., Heine, A., Kuhn, D., Supuran, C.T., Scozzafava, A., Klebe, G. J. Med. Chem. 2004, 47, 550-557.
21. de Leval, X., Julémont, F., Delarge, J., Sanna, V., Pirotte, B., Dogné, J.-M. Exp. Opin. Ther. Patents 2002, 12, 969-989.
22. Tive, L. Rheumatology 2000, 39 suppl. 2, 21-28.
23. Supuran, C.T., Scozzafava, A., Casini, A. Med. Res. Rev. 2003, 23, 146-189.
24. Supuran, C.T., Scozzafava, A. Exp. Opin. Ther. Patents 2002, 12, 217-242.
25. Smith, K.S., Ferry, J.G. FEMS Microbiol. Rev. 2000, 24, 335-366.
26. Supuran, C.T., Scozzafava, A. Exp. Opin. Ther. Patents 2000, 10, 575-600.
27. Stams, T., Christianson, D.W. X-ray crystallographic studies of mammalian carbonic anhydrase isozymes. In The Carbonic Anhydrases - New Horizons; Chegwidden W.R., Edwards, Y., Carter, N. Eds.; Birkhauser Verlag, Basel, 2000, pp. 159-174.
28. Briganti, F., Mangani, S., Orioli, P., Scozzafava, A., Vernaglione, G., and Supuran, C.T. Biochemistry 1997, 36, 10384-10392.
29. Abbate, F.; Supuran, C.T.; Scozzafava, A.; Orioli, P.; Stubbs, M.T.; Klebe, G. J. Med. Chem., 2002, 45, 3583-3587.
30. Casini, A., Abbate, F.; Scozzafava, A., Supuran, C.T. Bioorg. Med. Chem. Lett., 2003, 13, 2759-2763.
31. Abbate, F.; Casini, A., Scozzafava, A., Supuran, C.T. J. Enz. Inhib. Med. Chem. 2003, 18, 303-308.
32. Abbate, F., Casini, A., Owa, T., Scozzafava, A., Supuran, C.T. Bioorg. Med. Chem. Lett. 2004, 14, 217-223.
33. Winum, J.-Y., Vullo, D., Casini, A., Montero, J.-L., Scozzafava, A., Supuran, C.T. (2003) J. Med. Chem. 46, 2197-2204.
34. Vullo, D., Franchi, M., Gallori, E., Pastorek, J., Scozzafava, A., Pastorekova, S., and Supuran, C.T. Bioorg. Med. Chem. Lett. 2003, 13, 1005-1009.
35. Chegwidden, W.R., Spencer, I.M., Supuran, C.T. The roles of carbonic anhydrase isozymes in cancer. In Gene Families: Studies of DNA, RNA, Enzymes and Proteins, Xue G., Xue, Y., Xu, Z., Holmes, R., Hammond, G.L., Lim, H.A. Eds., World Scientific, Singapore 2001, pp. 157-170.
36. Scozzafava, A., Supuran, C.T. Bioorg. Med. Chem. Lett. 2000, 10, 1117-1120.
37. Supuran, C.T., Scozzafava, A. J. Enzyme Inhib. 2000, 15, 597-610.
38. Supuran, C.T., Scozzafava, A. Eur. J. Med. Chem. 2000, 35, 867-874.
39. Supuran, C.T., Briganti, F., Tilli, S., Chegwidden, W.R., Scozzafava, A. Bioorg. Med. Chem. 2001, 9, 703-714.
40. Parkkila, S., Rajaniemi, H., Parkkila, A.K., Kivela, J., Waheed, A., Pastorekova, S., Pastorek, J., Sly, W.S. Proc. Natl. Acad. Sci. USA 2000, 97, 2220-2224.
41. Saarnio, J., Parkkila, S., Parkkila, A.K., Pastorekova, S., Haukipuro, K., Pastorek, J., Juvonen, T., Karttunen, T.J. J. Hepatol. 2001, 35, 643-649.
42. Giatromanolaki, A., Koukourakis, M.I., Sivridis, E., Pastorek, J., Wykoff, C.C., Gatter, K.C., Harris, A.L. Cancer Res. 2001, 61, 7992-7998.
43. Chia, S.K., Wykoff, C.C., Watson, P.H., Han, C., Leek, R.D., Pastorek, J., Gatter, K.C., Ratcliffe, P., Harris, A.L. J. Clin. Oncol. 2001, 19, 3660-3668.
44. Loncaster, JA., Harris, A.L., Davidson, S.E., Logue, J.P., Hunter, R.D., Wycoff, C.C., Pastorek, J., Ratcliffe, P.J., Stratford, I.J., West, C.M. Cancer Res. 2001, 61, 6394-6399.
45. Wykoff, C.C., Beasley, N., Watson, P.H., Campo, L., Chia, S.K., English, R., Pastorek, J., Sly, W.S., Ratcliffe, P., Harris, A.L. Am. J. Pathol. 2001, 158, 1011-1019.
46. Beasley, N.J., Wykoff, C.C., Watson, P.H., Leek, R., Turley, H., Gatter, K., Pastorek, J., Cox, G.J., Ratcliffe, P., Harris, A.L. Cancer Res. 2001, 61, 5262-5267.
47. Kivela, A.J., Saarnio, J., Karttunen, T.J., Kivela, J., Parkkila, A.K., Pastorekova, S., Pastorek, J., Waheed, A., Sly, W.S., Parkkila, S., Rajaniemi, H. Dig. Dis. Sci. 2001, 46, 2179-2186.
48. Parkkila, S., Parkkila, A.K., Saarnio, J., Kivela, J., Karttunen, T.J., Kaunisto, K., Waheed, A., Sly, W.S., Tureci, O., Virtanen, I., Rajaniemi, H. J. Histochem. Cytochem. 2000, 48, 1601-1608.
49. Sari, R., Camci, C., Kutlu, R., Totan, Y., Sevinc, A., Buyukberber, S. Int. J. Clin. Pract. 2001, 55, 488-490.
50. Supuran, C.T., Scozzafava, A., Conway, J. (Eds.) Carbonic Anhydrase - Its Inhibition and Activation. CRC Press. Boca Raton. FL (USA) 2004, pp. 1-384.